Want to see KR:118000 full AI Analyst Report?
Metacare Co., Ltd. (118000) Ratios
Metacare Co., Ltd. Ratios
KR:118000's free cash flow for Q2 2026 was $956.73M. For the 2026 fiscal year, KR:118000's free cash flow was decreased by $-23.57M and operating cash flow was $980.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.56 | 3.61 | 3.34 | 1.52 | 1.55 |
| Quick Ratio | 0.54 | 3.53 | 2.76 | 1.19 | 1.52 |
| Cash Ratio | 0.03 | 2.52 | 1.26 | 0.59 | 1.11 |
| Solvency Ratio | 0.05 | 0.30 | -0.56 | -0.79 | 0.16 |
| Operating Cash Flow Ratio | 0.05 | 0.37 | -0.81 | -0.05 | -0.03 |
| Short-Term Operating Cash Flow Coverage | 0.07 | 0.63 | -5.05 | -0.11 | -0.05 |
| Net Current Asset Value | $ -47.85B | $ 2.16B | $ 35.67B | $ 13.20B | $ 25.53B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.30 | 0.23 | 0.02 | 0.18 | 0.17 |
| Debt-to-Equity Ratio | 0.50 | 0.31 | 0.03 | 0.35 | 0.25 |
| Debt-to-Capital Ratio | 0.33 | 0.24 | 0.03 | 0.26 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.19 | 0.00 | 0.09 | 0.00 |
| Financial Leverage Ratio | 1.66 | 1.35 | 1.47 | 1.91 | 1.48 |
| Debt Service Coverage Ratio | 0.12 | 0.80 | 0.54 | -2.06 | 0.51 |
| Interest Coverage Ratio | 0.54 | 3.77 | 0.30 | -0.05 | -0.23 |
| Debt to Market Cap | 1.13 | 0.81 | 0.06 | 0.78 | 0.30 |
| Interest Debt Per Share | 3595.92 | 2377.30 | 633.66 | 4836.66 | 5732.73 |
| Net Debt to EBITDA | 12.47 | 0.91 | -5.30 | -0.24 | -1.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.72% | 37.97% | 37.83% | 34.12% | 27.38% |
| EBIT Margin | 4.04% | 15.22% | 5.81% | -155.20% | 81.29% |
| EBITDA Margin | 14.10% | 30.10% | 18.30% | -144.93% | 89.42% |
| Operating Profit Margin | 4.04% | 7.45% | 5.81% | -1.57% | -9.59% |
| Pretax Profit Margin | -0.62% | 13.24% | -26.33% | -259.47% | 40.28% |
| Net Profit Margin | 1.52% | 45.91% | -84.26% | -259.47% | 41.58% |
| Continuous Operations Profit Margin | -0.65% | 13.24% | -26.35% | -259.47% | 52.95% |
| Net Income Per EBT | -243.15% | 346.73% | 320.03% | 100.00% | 103.24% |
| EBT Per EBIT | -15.47% | 177.78% | -453.13% | 16492.40% | -419.91% |
| Return on Assets (ROA) | 0.25% | 5.92% | -9.36% | -26.10% | 4.39% |
| Return on Equity (ROE) | 0.42% | 8.02% | -13.73% | -49.93% | 6.48% |
| Return on Capital Employed (ROCE) | 0.91% | 1.04% | 0.72% | -0.21% | -1.45% |
| Return on Invested Capital (ROIC) | 0.73% | 0.99% | 0.70% | -0.18% | -1.17% |
| Return on Tangible Assets | 0.28% | 6.29% | -11.39% | -31.31% | 4.73% |
| Earnings Yield | 0.95% | 21.74% | -33.50% | -114.89% | 7.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.54 | 2.34 | 0.90 | 0.74 | 0.96 |
| Payables Turnover | 8.00 | 3.82 | 2.90 | 2.14 | 5.77 |
| Inventory Turnover | 25.19 | 12.69 | 1.16 | 0.80 | 7.98 |
| Fixed Asset Turnover | 7.68 | 7.06 | 9.13 | 11.80 | 62.41 |
| Asset Turnover | 0.17 | 0.13 | 0.11 | 0.10 | 0.11 |
| Working Capital Turnover Ratio | 7.75 | 0.59 | 0.55 | 0.71 | 7.78 |
| Cash Conversion Cycle | 112.62 | 89.03 | 595.80 | 780.43 | 364.51 |
| Days of Sales Outstanding | 143.77 | 155.90 | 407.39 | 491.94 | 382.02 |
| Days of Inventory Outstanding | 14.49 | 28.77 | 314.24 | 459.10 | 45.74 |
| Days of Payables Outstanding | 45.64 | 95.64 | 125.83 | 170.61 | 63.25 |
| Operating Cycle | 158.26 | 184.68 | 721.63 | 951.04 | 427.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 140.86 | 295.89 | -1220.27 | -301.38 | -228.10 |
| Free Cash Flow Per Share | -1326.66 | 104.29 | -1698.17 | -321.19 | -232.69 |
| Dividend Paid and CapEx Coverage Ratio | 0.10 | 1.54 | -2.55 | -15.22 | -49.76 |
| Capital Expenditure Coverage Ratio | 0.10 | 1.54 | -2.55 | -15.22 | -49.76 |
| Operating Cash Flow Coverage Ratio | 0.04 | 0.13 | -3.83 | -0.07 | -0.05 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.22 | -0.75 | -0.13 | -0.08 |
| Free Cash Flow Yield | -43.50% | 3.70% | -41.22% | -6.25% | -1.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 103.15 | 4.60 | -2.99 | -0.87 | 12.72 |
| Price-to-Sales (P/S) Ratio | 1.60 | 2.11 | 2.52 | 2.26 | 5.29 |
| Price-to-Book (P/B) Ratio | 0.44 | 0.37 | 0.41 | 0.43 | 0.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.30 | 27.04 | -2.43 | -16.00 | -64.68 |
| Price-to-Operating Cash Flow Ratio | 21.65 | 9.53 | -3.38 | -17.05 | -65.98 |
| Price-to-Earnings Growth (PEG) Ratio | -1.08 | -0.03 | 0.04 | 0.00 | -0.25 |
| Enterprise Value Multiple | 23.79 | 7.92 | 8.45 | -1.80 | 4.15 |
| Enterprise Value | 110.12B | 48.18B | 26.68B | 49.70B | 69.03B |
| EV to EBITDA | 23.79 | 7.92 | 8.45 | -1.80 | 4.15 |
| EV to Sales | 3.36 | 2.38 | 1.55 | 2.60 | 3.71 |
| EV to Free Cash Flow | -4.83 | 30.53 | -1.49 | -18.44 | -45.37 |
| EV to Operating Cash Flow | 45.51 | 10.76 | -2.08 | -19.65 | -46.28 |
| Tangible Book Value Per Share | 5874.68 | 7037.78 | 10441.38 | 11678.00 | 16297.37 |
| Shareholders’ Equity Per Share | 6952.15 | 7644.84 | 10051.57 | 11826.41 | 18259.46 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | 0.00 | -0.00 | -0.66 | -0.31 |
| Revenue Per Share | 1910.75 | 1335.53 | 1637.84 | 2275.91 | 2846.47 |
| Net Income Per Share | 29.01 | 613.08 | -1380.00 | -5905.35 | 1183.64 |
| Tax Burden | -2.43 | 3.47 | 3.20 | 1.00 | 1.03 |
| Interest Burden | -0.15 | 0.87 | -4.53 | 1.67 | 0.50 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.07 | 0.12 | 0.00 |
| SG&A to Revenue | 0.06 | 0.07 | 0.08 | 0.10 | 0.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Income Quality | 19.37 | 0.53 | 0.88 | 0.05 | -0.20 |
Currency in KRW